Kenilworth Systems Corporation
KENS
$0.28
$0.000.00%
| Weiss Ratings | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.94 | |||
| Price History | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 210.77% | |||
| 30-Day Total Return | 0.39% | |||
| 60-Day Total Return | 16.67% | |||
| 90-Day Total Return | -5.88% | |||
| Year to Date Total Return | 0.04% | |||
| 1-Year Total Return | 42.86% | |||
| 2-Year Total Return | 495.74% | |||
| 3-Year Total Return | -20.00% | |||
| 5-Year Total Return | 671.35% | |||
| 52-Week High % Change | -30.00% | |||
| 52-Week Low % Change | 34,900.00% | |||
| Price | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.40 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Nov 07, 2024 | |||
| 52-Week High Price (Date) | Aug 06, 2024 | |||
| Valuation | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 23.42M | |||
| Enterprise Value | 23.43M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -81.70% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -2,800.00 | |||
| Price/Book (Q) | -560.00 | |||
| Enterprise Value/Revenue (TTM) | -1,673.45 | |||
| Price | $0.28 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -82.32 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 79.65M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 312 372 6900 | |||
| Address | 721 Beach Street Daytona Beach, FL 32114 | |||
| Website | -- | |||
| Country | United States | |||
| Year Founded | 1968 | |||
| Profitability | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 2,032.85% | |||
| Profit Margin | 2,367.85% | |||
| Management Effectiveness | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -300.97% | |||
| Return on Equity | -- | |||
| Income Statement | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -14.00K | |||
| Total Revenue (TTM) | -14.00K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -14.00K | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -284.60K | |||
| Net Income (TTM) | -331.50K | |||
| Net Income Avl. to Common (TTM) | -331.50K | |||
| Total Revenue Growth (Q YOY) | -100.00% | |||
| Earnings Growth (Q YOY) | 54.25% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 95.35% | |||
| Balance Sheet | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 900.00 | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 49.40K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -32.60K | |||
| Current Ratio (Q) | 0.602 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 49.40K | |||
| Total Current Liabilities (Q) | 82.00K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 82.00K | |||
| Total Common Equity (Q) | -38.50K | |||
| Cash Flow | KENS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -300.45M | |||
| Cash from Financing (TTM) | 300.80M | |||
| Net Change in Cash (TTM) | -14.40K | |||
| Levered Free Cash Flow (TTM) | -300.70M | |||
| Cash from Operations (TTM) | -368.70K | |||
